This 2-day course will provide an introduction to the methods of health technology assessment. There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems. The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis. There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA such as treatment switching, extrapolation, and network meta-analysis. Attendees will be encouraged to share their own HTA experiences.
Mark Sculpher, Professor of Health Economics and Director of the Programme on Economic Evaluation and Health Technology Assessment at the University of York.
Neil Hawkins, Professor of Health Economics and Health Technology Assessment at the University of Glasgow.
Jan McKendrick, Senior Director at PRMA Consulting Ltd.
Anja Schiel, Senior Advisor and Statistician and the Norwegian Medicines Agency (NoMA)
Jonathan Alsop, Director at Numerus.
Course runs from:
Day 1: 09:00 – 17:30 (registration from 8:30)
Day 2: 09:00 – 15:30
Registration has now closed.
PSI are holding a limited number of reduced price hotel rooms at Gothia Towers until the 23rd March which will be allocated on a first come first served basis.
Registration costs (includes lunch and refreshments)
Before 23rd March
After 23rd March
PSI are holding a limited number of hotel rooms at Gothia Towers on 23rd and 24th April which will be allocated on a first come first served basis. Rooms will be charged at £115 per room per night including breakfast. Please contact email@example.com to make a reservation.
Joint PSI, EFSPI & ASA BIOP Webinar: Estimands
PSI, the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) and the Biopharmaceutical Section of the American Statistical Association (ASA) are jointly organising a webinar on Estimands in Practice. Speakers from regulatory authorities (FDA and EMA) and industry will present on their experience on this topic to date.
Discover your potential by working as a Covance Senior Principal / Principal Biostatistician. You'll enjoy a varied role working for different sponsors across several therapeutic areas, leading projects and mentoring junior members of the department.
Biometrics at AstraZeneca provides the data that influences decisions on how we roll back the frontiers of science to bring life-changing medicines to the world. We are at the heart of design, analytics and interpretation of AstraZeneca’s portfolio.